---
figid: PMC7162828__18_2019_3332_Fig3_HTML
figlink: pmc/articles/PMC7162828/figure/Fig3/
number: F3
caption: 'A schematic presentation of selected cellular processes influenced by KYNA.
  KYNA inhibits phosphorylation of protein kinase B (Akt), extracellular signal-regulated
  kinase (ERK 1/2), and p38 mitogen-activated protein kinase (p38) []. The effect
  of KYNA on phosphoinositide 3-kinase/protein kinase B PI3K/Akt pathway may lead
  to disruption of various cellular processes including proliferation, cell cycle,
  cell survival and migration. Interaction between KYNA and ERK pathway may affect
  the processes of differentiation, proliferation or apoptosis, whereas interaction
  between KYNA and p38 pathway may affect the processes of proliferation, cell motility,
  apoptosis, stress response and inflammation. Moreover, KYNA enhances the protein
  expression of β-catenin which is involved in adhesion, development, cell survival
  and proliferation. The potential relationship between AhR (a) and GPR35 (b) receptors
  and mentioned signalling pathways is presented; however, the specific mechanism
  of KYNA interactions has not been fully elucidated. a KYNA is an agonist of the
  aryl hydrocarbon receptor AhR. According to the biological effects of AhR activation,
  three possible types of interactions may be suggested: via PI3K/Akt pathway, ERK
  signalling pathway or by activation of the expression of xenobiotic and non-xenobiotic
  target genes (based on [–]). b KYNA activates G-protein-coupled receptor 35 (GPR35)
  which may lead to inhibition of phosphorylation of various signalling proteins,
  including Akt, ERK, and p38 mitogen-activated protein kinase (p38). Additionally,
  activation of GPR35 may lead to increase in β-catenin expression (based on [, ]).
  c KYNA enhances the protein expression of cyclin-dependent kinase (CDK) inhibitor
  p21Waf1/Cip1 resulting in possible inhibition of cyclin D/CDK4/CDK6, cyclin E/CDK2,
  cyclin A/CDK2 and cyclin B/CDK1 complexes which may lead to cell cycle arrest and
  antiproliferative activity []'
pmcid: PMC7162828
papertitle: 'Kynurenic acid and cancer: facts and controversies.'
reftext: Katarzyna Walczak, et al. Cell Mol Life Sci. 2020;77(8):1531-1550.
pmc_ranked_result_index: '1444'
pathway_score: 0.926862
filename: 18_2019_3332_Fig3_HTML.jpg
figtitle: Schematic presentation of selected cellular processes influenced by KYNA
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7162828__18_2019_3332_Fig3_HTML.html
  '@type': Dataset
  description: 'A schematic presentation of selected cellular processes influenced
    by KYNA. KYNA inhibits phosphorylation of protein kinase B (Akt), extracellular
    signal-regulated kinase (ERK 1/2), and p38 mitogen-activated protein kinase (p38)
    []. The effect of KYNA on phosphoinositide 3-kinase/protein kinase B PI3K/Akt
    pathway may lead to disruption of various cellular processes including proliferation,
    cell cycle, cell survival and migration. Interaction between KYNA and ERK pathway
    may affect the processes of differentiation, proliferation or apoptosis, whereas
    interaction between KYNA and p38 pathway may affect the processes of proliferation,
    cell motility, apoptosis, stress response and inflammation. Moreover, KYNA enhances
    the protein expression of β-catenin which is involved in adhesion, development,
    cell survival and proliferation. The potential relationship between AhR (a) and
    GPR35 (b) receptors and mentioned signalling pathways is presented; however, the
    specific mechanism of KYNA interactions has not been fully elucidated. a KYNA
    is an agonist of the aryl hydrocarbon receptor AhR. According to the biological
    effects of AhR activation, three possible types of interactions may be suggested:
    via PI3K/Akt pathway, ERK signalling pathway or by activation of the expression
    of xenobiotic and non-xenobiotic target genes (based on [–]). b KYNA activates
    G-protein-coupled receptor 35 (GPR35) which may lead to inhibition of phosphorylation
    of various signalling proteins, including Akt, ERK, and p38 mitogen-activated
    protein kinase (p38). Additionally, activation of GPR35 may lead to increase in
    β-catenin expression (based on [, ]). c KYNA enhances the protein expression of
    cyclin-dependent kinase (CDK) inhibitor p21Waf1/Cip1 resulting in possible inhibition
    of cyclin D/CDK4/CDK6, cyclin E/CDK2, cyclin A/CDK2 and cyclin B/CDK1 complexes
    which may lead to cell cycle arrest and antiproliferative activity []'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AHR
  - AKT2
  - AKT3
  - AKT1
  - MAPK14
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK3
  - MAPK1
  - CDK3
  - CDK5
  - CDK7
  - CDK9
  - CDK16
  - CDK17
  - CDK18
  - CDK14
  - CDKL5
  - CDK13
  - CDKL1
  - CDKL2
  - CDK20
  - CDKL3
  - CDK12
  - CDK15
  - CDKL4
  - CDK11A
  - CDK1
  - CDK11B
  - CDK2
  - CDK4
  - CDK6
  - CDK8
  - CDK10
  - CDK19
  - KYNA
  - cycin
  - Cancer
genes:
- word: AhR
  symbol: AHR
  source: hgnc_symbol
  hgnc_symbol: AHR
  entrez: '196'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: AhR
  symbol: AHR
  source: hgnc_symbol
  hgnc_symbol: AHR
  entrez: '196'
- word: CDK/cycin
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK3
  entrez: '1018'
- word: CDK/cycin
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK5
  entrez: '1020'
- word: CDK/cycin
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK7
  entrez: '1022'
- word: CDK/cycin
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK9
  entrez: '1025'
- word: CDK/cycin
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK16
  entrez: '5127'
- word: CDK/cycin
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK17
  entrez: '5128'
- word: CDK/cycin
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK18
  entrez: '5129'
- word: CDK/cycin
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK14
  entrez: '5218'
- word: CDK/cycin
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL5
  entrez: '6792'
- word: CDK/cycin
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK13
  entrez: '8621'
- word: CDK/cycin
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL1
  entrez: '8814'
- word: CDK/cycin
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL2
  entrez: '8999'
- word: CDK/cycin
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK20
  entrez: '23552'
- word: CDK/cycin
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL3
  entrez: '51265'
- word: CDK/cycin
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK12
  entrez: '51755'
- word: CDK/cycin
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK15
  entrez: '65061'
- word: CDK/cycin
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL4
  entrez: '344387'
- word: CDK/cycin
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK11A
  entrez: '728642'
- word: CDK/cycin
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK1
  entrez: '983'
- word: CDK/cycin
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK11B
  entrez: '984'
- word: CDK/cycin
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK2
  entrez: '1017'
- word: CDK/cycin
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: CDK/cycin
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: CDK/cycin
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK8
  entrez: '1024'
- word: CDK/cycin
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK10
  entrez: '8558'
- word: CDK/cycin
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK19
  entrez: '23097'
- word: CDK/
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK3
  entrez: '1018'
- word: CDK/
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK5
  entrez: '1020'
- word: CDK/
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK7
  entrez: '1022'
- word: CDK/
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK9
  entrez: '1025'
- word: CDK/
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK16
  entrez: '5127'
- word: CDK/
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK17
  entrez: '5128'
- word: CDK/
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK18
  entrez: '5129'
- word: CDK/
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK14
  entrez: '5218'
- word: CDK/
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL5
  entrez: '6792'
- word: CDK/
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK13
  entrez: '8621'
- word: CDK/
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL1
  entrez: '8814'
- word: CDK/
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL2
  entrez: '8999'
- word: CDK/
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK20
  entrez: '23552'
- word: CDK/
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL3
  entrez: '51265'
- word: CDK/
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK12
  entrez: '51755'
- word: CDK/
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK15
  entrez: '65061'
- word: CDK/
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL4
  entrez: '344387'
- word: CDK/
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK11A
  entrez: '728642'
- word: CDK/
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK1
  entrez: '983'
- word: CDK/
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK11B
  entrez: '984'
- word: CDK/
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK2
  entrez: '1017'
- word: CDK/
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: CDK/
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: CDK/
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK8
  entrez: '1024'
- word: CDK/
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK10
  entrez: '8558'
- word: CDK/
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK19
  entrez: '23097'
chemicals:
- word: KYNA
  source: MESH
  identifier: C548511
- word: cycin
  source: ''
  identifier: ''
diseases:
- word: Cancer
  source: MESH
  identifier: D009369
figid_alias: PMC7162828__F3
redirect_from: /figures/PMC7162828__F3
figtype: Figure
---
